文献速递贫血与红细胞疾病

HMGB1介导的EPO信号限制促进炎症性贫血

HMGB1-mediated restriction of EPO signaling contributes to anemia of inflammation.
PubMed 文献 · Blood · 2022-01-01

本研究探讨炎症性贫血对促红细胞生成素(EPO)治疗抵抗的机制,发现高迁移率族蛋白B1(HMGB1)可减少EPO敏感性红系前体细胞的扩增并增加其死亡,显著减弱EPO介导的JAK2/STAT5和mTOR信号通路磷酸化。表面等离子共振研究显示HMGB1可干扰EPO与EPOR的结合,而在小鼠脓毒症发生后给予抗HMGB1单克隆抗体可部分恢复体内EPO信号。

要点

  • HMGB1减少EPO敏感性红系前体细胞扩增并增加其死亡。
  • HMGB1显著减弱EPO介导的JAK2/STAT5和mTOR通路磷酸化。
  • 脓毒症后给予抗HMGB1单抗可部分恢复小鼠体内EPO信号。

核心结论

  • HMGB1介导的EPO信号限制促进炎症性贫血的慢性期。

研究设计与样本

  • 研究在人红系生成模型和小鼠中开展,具体样本量原文未报告。

主要发现

  • HMGB1导致人红系生成模型中EPO敏感性红系前体细胞扩增减少、死亡增加。
  • HMGB1显著减弱EPO介导的Janus激酶2/STAT5和mTOR信号通路磷酸化。
  • 敲除晚期糖基化终产物受体(红系前体细胞表达的唯一已知HMGB1受体)在人源或鼠源前体细胞中均不能挽救HMGB1对EPO信号的有害效应。
  • 表面等离子共振研究显示HMGB1能够干扰EPO与EPOR的结合。
  • 小鼠脓毒症发生后给予抗HMGB1单克隆抗体可部分恢复体内EPO信号。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Anemia of inflammation, also known as anemia of chronic disease, is refractory to erythropoietin (EPO) treatment, but the mechanisms underlying the EPO refractory state are unclear. Here, we demonstrate that high mobility group box-1 protein (HMGB1), a damage-associated molecular pattern molecule recently implicated in anemia development during sepsis, leads to reduced expansion and increased death of EPO-sensitive erythroid precursors in human models of erythropoiesis. HMGB1 significantly attenuates EPO-mediated phosphorylation of the Janus kinase 2/STAT5 and mTOR signaling pathways. Genetic ablation of receptor for advanced glycation end products, the only known HMGB1 receptor expressed by erythroid precursors, does not rescue the deleterious effects of HMGB1 on EPO signaling, either in human or murine precursors. Furthermore, surface plasmon resonance studies highlight the ability of HMGB1 to interfere with the binding between EPO and the EPOR. Administration of a monoclonal anti-HMGB1 antibody after sepsis onset in mice partially restores EPO signaling in vivo. Thus, HMGB1-mediated restriction of EPO signaling contributes to the chronic phase of anemia of inflammation.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Dulmovits BM, Tang Y, Papoin J, et al. HMGB1-mediated restriction of EPO signaling contributes to anemia of inflammation. Blood. 2022. PMID: 35040907. doi:10.1182/blood.2021012048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。